Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2C | P28335 | 9/20 | 0.48 |
| ▸ | HTR2B | P41595 | 6/20 | 0.45 |
| ▸ | HTR2A | P28223 | 4/20 | 0.45 |
| ▸ | GID4 | Q8IVV7 | 1/20 | 0.45 |
| ▸ | EPHX2 | P34913 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | DDR1 | Q08345 | 2/20 | 0.38 |
| ▸ | SRC | P12931 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6923415 | 0.81 | HTR2C (0.44) | HTR2CHTR2BHTR2AGID4EPHX2 | |
| SCHEMBL6923255 | 0.81 | HTR2C (0.46) | HTR2CHTR2BHTR2AGID4EPHX2 | |
| SCHEMBL6925573 | 0.79 | KDM4E (0.43) | HTR2CHTR2BHTR2AGID4EPHX2 | |
| SCHEMBL17231940 | 0.78 | HTR2C (0.58) | HTR2CHTR2BHTR2AGID4KDM4E | |
| SCHEMBL17231953 | 0.78 | HTR2C (0.58) | HTR2CHTR2BHTR2AGID4KDM4E | |
| SCHEMBL23997637 | 0.75 | HTR2C (0.50) | HTR2CHTR2BHTR2AGID4KDM4E | |
| SCHEMBL6923367 | 0.75 | HTR2C (0.50) | HTR2CHTR2BHTR2AGID4KDM4E | |
| SCHEMBL17231955 | 0.75 | HTR2C (0.57) | HTR2CGID4 | |
| SCHEMBL7376245 | 0.75 | KMT2A (0.39) | KDM4EALDH1A1SMN1; SMN2 | |
| SCHEMBL15298963 | 0.72 | ALDH1A1 (0.48) | HTR2CHTR2BHTR2AGID4KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2002050056-A1 | BENZYLAMINE DERIVATIVES AND THEIR USE AS THROMBIN INHIBITORS | MERCK & CO., INC. (US) | 2002-06-27 | — | — | WO | disclosed |